Related Experiment Video
Updated: Jul 30, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.4K
Robust Beam Selection Based on Water Equivalent Thickness Analysis in Passive Scattering Carbon-Ion Radiotherapy for
Yuan Zhou1, Makoto Sakai2, Yang Li2,3
1Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
Cancers
|May 13, 2023
Summary
Robust beam configurations (BC) improve passive carbon-ion radiotherapy (CIRT) for pancreatic cancer. This study identified optimal BCs using water equivalent thickness (WET) analysis, enhancing dose accuracy and target coverage.
Area of Science:
- Radiation Oncology
- Medical Physics
- Oncology
Background:
- Carbon-ion radiotherapy (CIRT) is a highly effective treatment modality.
- Passive CIRT requires robust beam configurations (BC) to account for variations like water equivalent thickness (WET).
Purpose of the Study:
- To select robust BCs for passive CIRT in pancreatic cancer using WET analysis.
- To evaluate the impact of robust BCs on dose distribution and accuracy.
Main Methods:
- Analysis of 110 CT images and 600 dose distributions from eight pancreatic cancer patients.
- Evaluation of robustness using planning and daily CT images, comparing bone matching (BM) and tumor matching (TM).
- Selection of two robust BCs (rotating gantry and fixed port) based on WET analysis.
Main Results:
- Posterior oblique (120-240°) and anteroposterior (0°, 180°) beams demonstrated the highest robustness to WET changes.
- Tumor matching (TM) with robust BCs resulted in mean CTV V95% reductions of -3.8% (gantry) and -5.2% (fixed port).
- Slight increases in OAR doses were observed with WET-based BCs but remained within constraints.
Conclusions:
- Robust BCs, identified through WET analysis, enhance the reliability of passive CIRT for pancreatic cancer.
- Tumor matching combined with robust BCs improves the accuracy of passive CIRT delivery.
- WET-robust BCs are crucial for optimizing dose distribution in pancreatic cancer CIRT.

